LBGPGpkk:p:20000BC02:16000BC12: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
|LipidBank=EEL0071 | |LipidBank=EEL0071 | ||
|SysName=2- (3'',7'',11''.15'',19''-pentamethyl) eicosyl-3- (3',7',11',15'-tetramethyl) hexadecyl-sn-glycerol-1-phosphoglycerophosphate | |SysName=2- (3'',7'',11''.15'',19''-pentamethyl) eicosyl-3- (3',7',11',15'-tetramethyl) hexadecyl-sn-glycerol-1-phosphoglycerophosphate | ||
|Common Name=&& | |Common Name=&&C20,C25-archaetidylglycerophosphate&&2- (3'',7'',11''.15'',19''-pentamethyl) eicosyl-3- (3',7',11',15'-tetramethyl) hexadecyl-sn-glycerol-1-phosphoglycerophosphate&& | ||
|Mass Spectra=negative FAB, m/z 972 (M-NH<SUB><FONT SIZE=-1>4</FONT></SUB>), | |Mass Spectra=negative FAB, m/z 972 (M-NH<SUB><FONT SIZE=-1>4</FONT></SUB>), | ||
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR, 0.82 (CH<SUB><FONT SIZE=-1>3</FONT></SUB>); 1.0-1.1 ((CH<SUB><FONT SIZE=-1>3</FONT></SUB>)<SUB><FONT SIZE=-1>2</FONT></SUB>C-); 1.2-1.3 (CH<SUB><FONT SIZE=-1>2</FONT></SUB>); 1.48-1.50 (CH-); 3.42-3.44 (RCH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-); 3.56-3.58 (-CH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-R, -CH-O-R); 3.9-4.0 (-CH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-P), | |NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR, 0.82 (CH<SUB><FONT SIZE=-1>3</FONT></SUB>); 1.0-1.1 ((CH<SUB><FONT SIZE=-1>3</FONT></SUB>)<SUB><FONT SIZE=-1>2</FONT></SUB>C-); 1.2-1.3 (CH<SUB><FONT SIZE=-1>2</FONT></SUB>); 1.48-1.50 (CH-); 3.42-3.44 (RCH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-); 3.56-3.58 (-CH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-R, -CH-O-R); 3.9-4.0 (-CH<SUB><FONT SIZE=-1>2</FONT></SUB>-O-P), | ||
|Chromatograms=TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4) double development Rf 0.44 chloroform-methanol-acetic acid (65:4:35) Rf 0.54 chloroform-methanol-ammonia (65:35:5) double development Rf 0.27 <<0036>>, | |Chromatograms=TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4) double development Rf 0.44 chloroform-methanol-acetic acid (65:4:35) Rf 0.54 chloroform-methanol-ammonia (65:35:5) double development Rf 0.27 <<0036>>, | ||
}} | }} | ||
Revision as of 11:00, 8 July 2009
| IDs and Links | |
|---|---|
| LipidBank | EEL0071 |
| LipidMaps | [1] |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBGPGpkk:p:20000BC02:16000BC12 |
| C20,C25-archaetidylglycerophosphate | |
|---|---|
| |
| Structural Information | |
| 2- (3,7,11.15,19-pentamethyl) eicosyl-3- (3',7',11',15'-tetramethyl) hexadecyl-sn-glycerol-1-phosphoglycerophosphate | |
| |
| Formula | |
| Exact Mass | |
| Average Mass | |
| SMILES | |
| Physicochemical Information | |
| Spectral Information | |
| Mass Spectra | negative FAB, m/z 972 (M-NH4), |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | 1H-NMR, 0.82 (CH3); 1.0-1.1 ((CH3)2C-); 1.2-1.3 (CH2); 1.48-1.50 (CH-); 3.42-3.44 (RCH2-O-); 3.56-3.58 (-CH2-O-R, -CH-O-R); 3.9-4.0 (-CH2-O-P), |
| Other Spectra | |
| Chromatograms | TLC, chloroform-methanol-acetic acid-water (85:22.5:10:4) double development Rf 0.44 chloroform-methanol-acetic acid (65:4:35) Rf 0.54 chloroform-methanol-ammonia (65:35:5) double development Rf 0.27 <<0036>>, |
